Mutations based on viral decay acceleration in the HIV-1 genomes of a clinical population treated with the mutagenic nucleoside KP1461

Benzer Materyaller

• Mutation of HIV-1 Genomes in a Clinical Population Treated with the Mutagenic Nucleoside KP1461
  Yazar:: Mullins, James I., ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• The chemistry and biology of KP-1461, a selective nucleoside mutagen for HIV therapy
  Yazar:: Harris, Kevin, ve diğerleri
  Baskı/Yayın Bilgisi: (2006)
• Lethal mutagenesis of HIV with mutagenic nucleoside analogs
  Yazar:: Loeb, Lawrence A., ve diğerleri
  Baskı/Yayın Bilgisi: (1999)
• Two-dimensional IR spectroscopy of the anti-HIV agent KP1212 reveals protonated and neutral tautomers that influence pH-dependent mutagenicity
  Yazar:: Peng, Chunte Sam, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Tautomerism provides a molecular explanation for the mutagenic properties of the anti-HIV nucleoside 5-aza-5,6-dihydro-2′-deoxycytidine
  Yazar:: Li, Deyu, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)